Recent Patent Reform Bills and Their Implications for Prescription Drugs

This Viewpoint discusses 3 bills introduced recently in Congress that focus on patent eligibility, fraud, and quality and that have major implications for clinical medicine and pharmaceutical development.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAMA : the journal of the American Medical Association 2023-02, Vol.329 (6), p.459-460
Hauptverfasser:	Tu, S. Sean, Nagar, Sarosh, Kesselheim, Aaron S
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical medicine Fraud Health Care Reform - legislation & jurisprudence Legislation, Drug Patents as Topic - legislation & jurisprudence Prescription Drugs United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This Viewpoint discusses 3 bills introduced recently in Congress that focus on patent eligibility, fraud, and quality and that have major implications for clinical medicine and pharmaceutical development.
ISSN:	0098-7484 1538-3598
DOI:	10.1001/jama.2022.24983